Romanian Registry of Hypertrophic Cardiomyopathy – overview of general characteristics and therapeutic choices at a national level

1. SEN-CHOWDHRY S., JACOBY D., MOON JC., MCKENNA WJ. Update on hypertrophic cardiomyopathy and a guide to the guidelines. Nat Rev Cardiol. 2016; 13(11):651-675.10.1038/nrcardio.2016.140Search in Google Scholar

2. ELLIOTT PM., ANASTASAKIS A., BORGER MA., BORGGREFE M., CECCHI F., CHARRON P., et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur. Heart J. 2014; 35(39):2733-79.10.1093/eurheartj/ehu284Search in Google Scholar

3. MARON BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002; 287(10):1308-20.10.1001/jama.287.10.1308Search in Google Scholar

4. ELLIOTT P., CHARRON P., BLANES JR., TAVAZZI L., TENDERA M., KONTÉ M., LAROCHE C., et al. European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology. 2016; 37(2):164-73.10.1093/eurheartj/ehv497Search in Google Scholar

5. CHARRON P., ELLIOTT PM., GIMENO JR., CAFORIO ALP., KASKI JP., TAVAZZI L., et al. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies. Eur Heart J. 2018 (doi: 10.1093/eurheartj/ehx819).10.1093/eurheartj/ehx819)Open DOISearch in Google Scholar

6. OLIVOTTO I., MARON MS., ADABAG AS., CASEY SA., VARGIU D., LINK MS., et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005; 46(3):480-7.10.1016/j.jacc.2005.04.043Search in Google Scholar

7. MARON BJ., MARON MS. Hypertrophic cardiomyopathy. Lancet. 2013; 381(9862):242-55.10.1016/S0140-6736(12)60397-3Search in Google Scholar

8. OLIVOTTO I., CECCHI F., CASEY SA., DOLARA A., TRAVERSE JH., MARON BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001; 104(21):2517-24.10.1161/hc4601.097997Search in Google Scholar

9. GUTTMANN OP., RAHMAN MS., O’MAHONY C., ANASTASAKIS A., ELLIOTT PM. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart. 2014; 100(6):465-72.10.1136/heartjnl-2013-304276Search in Google Scholar

10. CECCHI F., OLIVOTTO I., BETOCCHI S., RAPEZZI C., CONTE MR., SINAGRA G., et al. The Italian registry for hypertrophic cardiomyopathy: A nationwide survey. Am Heart J. 2005; 150(5):947-54.10.1016/j.ahj.2005.01.005Search in Google Scholar

11. APETREI E., COMAN I., GEORGESCU G., CAPRARU C., PETRE D. Correlation between ECG and echocardiographical changes in 145 cases of hypertrophic cardiomyopathy. Proceedings 14th Int. Congr. Electrocardiol. Berlin, 1997; 591-4.10.1515/9783112484289-130Search in Google Scholar

12. MONSERRAT L., ELLIOTT PM., GIMENO JR., SHARMA S., PENAS-LADO M., MCKENNA WJ. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003; 42(5):873-9.10.1016/S0735-1097(03)00827-1Search in Google Scholar

13. ADABAG AS., CASEY SA., KUSKOWSKI MA., ZENOVICH AG., MARON BJ. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Col. Cardiol. 2005; 45(5):697-704.10.1016/j.jacc.2004.11.043Search in Google Scholar

14. MARON MS, OLIVOTTO I, ZENOVICH AG, LINK MS, PANDIAN NG, KUVIN JT, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006; 114(21):2232-9.10.1161/CIRCULATIONAHA.106.64468217088454Search in Google Scholar

15. TO AC., DHILLON A., DESAI MY. Cardiac magnetic resonance in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2011; 4(10):1123-37.10.1016/j.jcmg.2011.06.02221999873Search in Google Scholar

16. O’HANLON R., GRASSO A., ROUGHTON M., MOON JC., CLARK S., WAGE R., et al. Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2010; 56(11):867-74.10.1016/j.jacc.2010.05.01020688032Search in Google Scholar

17. SPOLADORE R., MARON MS., D’AMATO R., CAMICI PG., OLIVOTTO I. Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence. Eur Heart J. 2012; 33(14):1724-33.10.1093/eurheartj/ehs15022719025Search in Google Scholar

18. APETREI E., SEGGEWISS H., DELEANU D., POPESCU BA., ZARMA L., COMAN IM. Ablaţia miocardică septală percutanată în cardiomiopatia hipertrofică obstructivă. Rev Rom Cardiol. 1991; 9:134-40.Search in Google Scholar